Q3 2024 · 13F-HR
Stonepine Capital Management, LLCholdings as filed
Filed 2024-11-13 · accession 0000935836-24-000663
$158.2M
Reported value
38
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 000899104 | ADMA | ADMA BIOLOGICS INC | $37.4M | 23.6% | 1,870,000 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $22.2M | 14.0% | 1,369,821 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $13.8M | 8.71% | 478,659 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC US LISTED | $6.1M | 3.87% | 55,000 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $6.0M | 3.79% | 212,000 | Common | SOLE |
| 98419J206 | XOMA | XOMA CORP | $5.2M | 3.26% | 195,096 | Common | SOLE |
| 766559702 | RIGL | RIGEL PHARMACEUTICALS INC | $5.0M | 3.16% | 309,100 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $4.9M | 3.07% | 700,000 | Common | SOLE |
| 035255108 | ANIK | ANIKA THERAPEUTICS INC | $4.7M | 2.95% | 189,308 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $4.3M | 2.69% | 820,000 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $4.1M | 2.60% | 1,000,000 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $3.9M | 2.48% | 1,310,287 | Common | SOLE |
| 68404V100 | — | OPTINOSE INC | $3.8M | 2.41% | 5,688,590 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $3.6M | 2.25% | 280,345 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $3.6M | 2.24% | 778,874 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HOLDINGS | $3.2M | 2.05% | 75,000 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $3.0M | 1.91% | 196,895 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $2.9M | 1.81% | 205,675 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $2.8M | 1.79% | 2,458,873 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $2.8M | 1.77% | 1,110,000 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $2.6M | 1.66% | 270,000 | Common | SOLE |
| 30068X103 | XGN | EXAGEN INC | $1.7M | 1.04% | 534,398 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $1.5M | 0.96% | 999,790 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $1.3M | 0.83% | 110,000 | Common | SOLE |
| 054754858 | AYTU | AYTU BIOPHARMA INC | $1.2M | 0.74% | 500,958 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $1.2M | 0.73% | 1,491,305 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $877,602 | 0.55% | 609,446 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $822,650 | 0.52% | 88,457 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $766,356 | 0.48% | 114,724 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $740,784 | 0.47% | 202,400 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $476,454 | 0.30% | 138,504 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $472,000 | 0.30% | 100,000 | Common | SOLE |
| 62857J201 | MYO | MYOMO INC | $401,000 | 0.25% | 100,000 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $377,229 | 0.24% | 137,174 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $306,300 | 0.19% | 30,000 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $173,000 | 0.11% | 50,000 | Common | SOLE |
| 92765F108 | RYI | VIRACTA THERAPEUTICS INC | $115,700 | 0.07% | 500,000 | Common | SOLE |
| 016CVR029 | — | ALIMERA SCIENCES INC CVR | $96,339 | 0.06% | 2,408,469 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.